Lataa...

Synthetic Lethal Networks for Precision Oncology: Promises and Pitfalls

Synthetic lethal interactions, in which the simultaneous loss-of-function of two genes produces a lethal phenotype, are being explored as a means to therapeutically exploit cancer-specific vulnerabilities and expand the scope of precision oncology. Currently, three FDA approved drugs work by targeti...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Mol Biol
Päätekijät: Shen, John Paul, Ideker, Trey
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2018
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6097899/
https://ncbi.nlm.nih.gov/pubmed/29932943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmb.2018.06.026
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!